Alligator Bioscience AB (publ) (STO:ATORX)
Sweden · Delayed Price · Currency is SEK 0.2044
-0.0056 (-2.67%)
Feb 11, 2026, 9:28 AM CET
Alligator Bioscience AB Revenue
Alligator Bioscience AB had revenue of 384.00K SEK in the quarter ending September 30, 2025, a decrease of -74.33%. This brings the company's revenue in the last twelve months to 46.22M, up 66.41% year-over-year. In the year 2024, Alligator Bioscience AB had annual revenue of 57.72M, down -2.58%.
Revenue (ttm)
46.22M
Revenue Growth
+66.41%
P/S Ratio
2.43
Revenue / Employee
3.56M
Employees
13
Market Cap
112.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 57.72M | -1.53M | -2.58% |
| Dec 31, 2023 | 59.25M | 23.25M | 64.58% |
| Dec 31, 2022 | 36.00M | 22.67M | 170.14% |
| Dec 31, 2021 | 13.33M | 7.81M | 141.65% |
| Dec 31, 2020 | 5.52M | 1.16M | 26.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IRLAB Therapeutics AB | 85.56M |
| Alzinova AB | 26.12M |
| Scandinavian ChemoTech AB | 11.68M |
| Biovica International AB | 9.89M |
| Spago Nanomedical AB | 5.84M |
| OncoZenge AB | 2.78M |
| Simris Group AB (PUBL) | 2.30M |
| Biosergen AB | 527.00K |
Alligator Bioscience AB News
- 3 months ago - Alligator Bioscience AB (STU:7AL0) Q3 2025 Earnings Call Highlights: Strategic Moves and ... - GuruFocus
- 3 months ago - Q3 2025 Alligator Bioscience AB Earnings Call Transcript - GuruFocus